person · Reporting owner

Cunningham David

Disclosed activity across 1 company

Tapewire entity: 117708
SEC CIK: 0001529247

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
IMMUCELL CORP /DE/ICCC · Entity 6837	Director	December 15, 2022	January 24, 2023

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

IMMUCELL CORP /DE/

Report date December 15, 2022 · Filed January 24, 2023

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Non Qualified Stock Options (Right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $6.52 · Expires 2027-12-15	Direct	10,000	Reported balance After 2022-12-15 transaction · row 1 Instrument identity requires review; Table II rows are not merged. 1 source row Row 1 · 2022-12-15 · Grant · Acquired 10,000 · Balance 10,000

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
December 15, 2022 Filed Jan 24, 2023 23:25 UTC	IMMUCELL CORP /DE/ ICCC · Entity 6837	GrantNon Qualified Stock Options (Right to buy) · Derivative	10,000	$6.52 Strike: $6.52	$65,200.00	Disclosure SEC source: 0001213900-23-004910 · ownership.xml · derivative · entry 1 Cunningham David · CIK 0001529247 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2027-12-15 Read SEC document
June 13, 2022 Filed Jun 14, 2022 12:01 UTC	IMMUCELL CORP /DE/ ICCC · Entity 6837	PurchaseCommon stock $0.10 per value per share	1,000	$8.00	$8,000.00	Disclosure SEC source: 0001213900-22-032625 · doc4.xml · nonDerivative · entry 1 Cunningham David · CIK 0001529247 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,000 Read SEC document
June 17, 2021 Filed Jun 21, 2021 18:34 UTC	IMMUCELL CORP /DE/ ICCC · Entity 6837	GrantIncentive Stock Options (Right to buy) · Derivative	10,000	$10.04 Strike: $10.04	$100,400.00	Disclosure SEC source: 0001213900-21-033249 · ownership.xml · derivative · entry 1 Cunningham David · CIK 0001529247 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2026-06-17 Read SEC document
March 12, 2020 Filed Mar 12, 2020 20:35 UTC	IMMUCELL CORP /DE/ ICCC · Entity 6837	PurchaseCommon Stock, par value $0.10 per share	2,000	$4.00	$8,000.00	Disclosure SEC source: 0001213900-20-006134 · doc4.xml · nonDerivative · entry 1 Cunningham David · CIK 0001529247 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Read SEC document
August 15, 2018 Filed Aug 16, 2018 17:03 UTC	IMMUCELL CORP /DE/ ICCC · Entity 6837	Disposition to issuerCommon Stock, par value $0.10 per share	930	$6.69	$6,221.70	Disclosure SEC source: 0001213900-18-011272 · doc4.xml · nonDerivative · entry 1 Cunningham David · CIK 0001529247 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,000 Read SEC document
March 19, 2018 Filed Mar 21, 2018 18:13 UTC	IMMUCELL CORP /DE/ ICCC · Entity 6837	GrantIncentive Stock Options (Right to buy) · Derivative	15,000	$7.08 Strike: $7.08	$106,200.00	Disclosure SEC source: 0001213900-18-003258 · doc4.xml · derivative · entry 1 Cunningham David · CIK 0001529247 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2028-03-19 Read SEC document
September 19, 2016 Filed Sep 21, 2016 19:26 UTC	IMMUCELL CORP /DE/ ICCC · Entity 6837	Exercise / conversionNon-qualified stock options (right to buy) · Derivative	10,000	$0.00 Strike: $5.75	$0.00	Disclosure SEC source: 0001547522-16-000302 · doc4.xml · derivative · entry 3 Cunningham David · CIK 0001529247 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2016-10-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
September 19, 2016 Filed Sep 21, 2016 19:26 UTC	IMMUCELL CORP /DE/ ICCC · Entity 6837	Exercise / conversionCommon Stock, par value $0.10 per share	10,000	$5.75	$57,500.00	Disclosure SEC source: 0001547522-16-000302 · doc4.xml · nonDerivative · entry 2 Cunningham David · CIK 0001529247 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,070 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
September 19, 2016 Filed Sep 21, 2016 19:26 UTC	IMMUCELL CORP /DE/ ICCC · Entity 6837	Disposition to issuerCommon Stock, par value $0.10 per share	7,334	$7.83	$57,425.22	Disclosure SEC source: 0001547522-16-000302 · doc4.xml · nonDerivative · entry 1 Cunningham David · CIK 0001529247 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,070 Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.